How the Indian cough syrup under scanner?

Indian cough syrup under scanner: Key points syrups came under scanner following the death of 66 kids in The Gambia​On Wednesday, the World Health (WHO) issued an alert over four cough syrups which are manufactured in India. The Indian manufactured cough syrups came under scanner following the death of 66 kids in The Gambia are...​The manufactured by Maiden Pharmaceuticals Limited (Haryana, India)." to acute kidney injuries"​The WHO has said that the contaminants found in the syrups are linked to death of those children." loss of these young lives is beyond heartbreaking for their families, the WHO Chief has in the alert. The US has a strict limitation on the use of these compounds. As per reports, the US government allows only 0.2% polyethylene glycol when polyethylene glycol is used as a food additive.​Human consumption of these contaminants is fatal​ glycol and ethylene glycol are toxic and when humans consume these compounds it leads to abdominal pain, vomiting, diarrhea, inability to pass urine, headache, altered mental state, and acute kidney injury and even death research studies have found the toxic nature of these compounds and the hazards they can put on a human body status are the initial symptoms, Acute kidney injury is usually the main cause of death, appearing between 8 and 24 hours after exposure to lethal doses says a study glycol poisoning can also result in hepatic disease, pancreatitis, and neurologic abnormalities, which appear up to a few days after exposure, it adds ethylene glycol is approximately 1400 mg per kg. Mass outbreaks from this contaminated compound were seen in Haiti in 1995-1996, Bangladesh in 1990 and Panama in 2006 a sweet-tasting, colorless, hygroscopic liquid commonly used in the commercial preparation of antifreeze, brake fluid, cigarettes, in India​The State Drug Controller had given licenses to the said Company only for export of these Cough Syrup,04 drugs manufactured only for exports by M/s. Maiden Pharmaceuticals Limited are not licensed for manufacture and sale in India. In effect, none of these four drugs of M/s. Maiden Pharmaceuticals is sold domestically in India, a press release from the Union health ministry said.​Pharma company website unavailable​not ascertain since when the website of the company has been unavailable from, information retrieved from search engines says the company's website was indexed ten years ago the cached version of the website says, "Maiden Pharmaceuticals Limited is a WHO-GMP & ISO 9001-2015 certified pharmaceutical company, started on 22ndalso says that the company has two manufacturing plants based in and has ​WHO denies claims over ​In the alert, the WHO has said that to date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products." batches of these products should be considered unsafe until they can be analyzed by the relevant National Regulatory Authorities," it has warned countries in circulation into restrict the consumption of these medicines, the global health leader has said that to date, these four products have been identified in The Gambia, but may have been distributed, through informal markets, to other countries or regions.